O Omnicell
| Market Cap | $1.79B |
| P/E Ratio | 982.88 |
| Forward P/E | 18.73 |
| Dividend Yield | — |
| Beta | 0.79 |
| 52W Range | $22.66 - $55.00 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Health Information Services |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 8 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER | Sale | 7,405 | $34.69 | $256.88K | 16 Mar 2026 | 15 Mar 2026 |
| Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER | Sale | 4,243 | $36.59 | $155.25K | 17 Feb 2026 | 18 Feb 2026 |
| Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER | Sale | 6,106 | $49.90 | $304.69K | 08 Jan 2026 | 12 Jan 2026 |
| Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER | Sale | 278 | $43.30 | $12.04K | 16 Dec 2025 | 17 Dec 2025 |
| Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER | Sale | 6,106 | $39.90 | $243.63K | 03 Dec 2025 | 05 Dec 2025 |
| LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEO | Sale | 28,250 | $35.97 | $1.02M | 01 Dec 2025 | 03 Dec 2025 |
| Randall A LippsCHAIRMAN, PRESIDENT AND CEO | Sale | 28,250 | $35.97 | $1.02M | 01 Dec 2025 | 03 Dec 2025 |
| Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER | Sale | 3,473 | $34.90 | $121.21K | 17 Nov 2025 | 18 Nov 2025 |
Frequently Asked Questions
What is OMCL stock price today?
Omnicell (OMCL) is currently trading at $39.32. The stock has a 52-week range of $22.66 to $55.00 and a market capitalization of $1.79B.
Is OMCL a good stock to buy in 2026?
Omnicell has a P/E ratio of 982.9 (forward P/E: 18.7), a dividend yield of none, and 1-year performance of +10.2%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling OMCL stock?
There have been 8 insider transactions for OMCL in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has OMCL stock performed over the past year?
Omnicell (OMCL) has returned +10.2% over the past 12 months. The stock traded between $22.66 and $55.00 during this period, and is currently at $39.32.
Which hedge funds own OMCL (Omnicell)?
0 tracked hedge funds currently hold OMCL in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is OMCL's market cap and valuation?
Omnicell (OMCL) has a market capitalization of $1.79B. The trailing P/E ratio is 982.9 and forward P/E is 18.7. The stock is classified in the Healthcare sector.
What is OMCL's revenue and profitability?
Omnicell reported revenue of $1.18B with net income of $2.05M and a profit margin of 0.00%. The stock has a beta of 0.79.
What sector is OMCL in and who are its biggest institutional holders?
Omnicell (OMCL) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.